Boehringer Ingelheim says pricing regime hinders access to treatments as group touts liver benefits from weight-loss drug
More than 40 million Americans are already opting to take on the cost of sick visits, drugs and surgeries to get lower premiums and tax savings.
States where voters bypassed officials to expand Medicaid are opting for stricter implementation of new requirements.
Hemab Therapeutics and Seaport Therapeutics are the newest biotech companies to join the public markets, each with an upsized IPO. According to IPO research firm Renaissance …
He didn’t just shout me a drink, he made me feel understood and seen. I’ve never forgotten his gestureI had picked up a box of books …